Which has preferable valuation & earnings, PNTG or BLLN?

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Pennant Group $947.71M 1.54 $29.58M $0.85 49.35 Billiontoone $305.11M 19.64 $7.45M $0.55 236.93

Does the media prefer PNTG or BLLN?

In the previous week, Billiontoone had 2 more articles in the media than The Pennant Group. MarketBeat recorded 11 mentions for Billiontoone and 9 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.70 beat Billiontoone's score of 0.64 indicating that The Pennant Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to RDNT or PNTG?

In the previous week, The Pennant Group had 5 more articles in the media than RadNet. MarketBeat recorded 9 mentions for The Pennant Group and 4 mentions for RadNet. RadNet's average media sentiment score of 0.78 beat The Pennant Group's score of 0.70 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PNTG or SHC?

In the previous week, The Pennant Group had 7 more articles in the media than Sotera Health. MarketBeat recorded 9 mentions for The Pennant Group and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.52 beat The Pennant Group's score of 0.70 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor PNTG or CAI?

In the previous week, The Pennant Group and The Pennant Group both had 9 articles in the media. Caris Life Sciences' average media sentiment score of 0.77 beat The Pennant Group's score of 0.70 indicating that Caris Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caris Life Sciences 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor VCYT or PNTG?

In the previous week, Veracyte had 1 more articles in the media than The Pennant Group. MarketBeat recorded 10 mentions for Veracyte and 9 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.70 beat Veracyte's score of 0.69 indicating that The Pennant Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

The Pennant Group (PNTG) Competitors

$41.95 +0.24 (+0.58%)

Closing price 04:00 PM Eastern

Extended Trading

$42.92 +0.97 (+2.32%)

As of 05:49 PM Eastern

Compare

PNTG vs. BLLN, RDNT, SHC, CAI, and VCYT

Should you buy The Pennant Group stock or one of its competitors? MarketBeat compares The Pennant Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with The Pennant Group include Billiontoone (BLLN), RadNet (RDNT), Sotera Health (SHC), Caris Life Sciences (CAI), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does The Pennant Group compare to Billiontoone?

The Pennant Group (NASDAQ:PNTG) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

85.9% of The Pennant Group shares are held by institutional investors. 6.9% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Billiontoone had 2 more articles in the media than The Pennant Group. MarketBeat recorded 11 mentions for Billiontoone and 9 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.70 beat Billiontoone's score of 0.64 indicating that The Pennant Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

The Pennant Group presently has a consensus price target of $41.00, suggesting a potential downside of 2.26%. Billiontoone has a consensus price target of $126.00, suggesting a potential downside of 3.31%. Given The Pennant Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe The Pennant Group is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

The Pennant Group has a net margin of 2.96% compared to Billiontoone's net margin of 0.00%. The Pennant Group's return on equity of 10.07% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
Billiontoone	N/A	N/A	N/A

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.54	$29.58M	$0.85	49.35
Billiontoone	$305.11M	19.64	$7.45M	$0.55	236.93

Summary

The Pennant Group beats Billiontoone on 12 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to RadNet?

RadNet (NASDAQ:RDNT) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

RadNet presently has a consensus price target of $87.43, suggesting a potential upside of 40.58%. The Pennant Group has a consensus price target of $41.00, suggesting a potential downside of 2.26%. Given RadNet's higher probable upside, equities analysts clearly believe RadNet is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.80
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

The Pennant Group has a net margin of 2.96% compared to RadNet's net margin of -0.66%. The Pennant Group's return on equity of 10.07% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
The Pennant Group	2.96%	10.07%	4.23%

The Pennant Group has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.40	-$18.65M	-$0.18	N/A
The Pennant Group	$947.71M	1.54	$29.58M	$0.85	49.35

RadNet has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market.

77.9% of RadNet shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 6.9% of The Pennant Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, The Pennant Group had 5 more articles in the media than RadNet. MarketBeat recorded 9 mentions for The Pennant Group and 4 mentions for RadNet. RadNet's average media sentiment score of 0.78 beat The Pennant Group's score of 0.70 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
The Pennant Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

The Pennant Group beats RadNet on 11 of the 17 factors compared between the two stocks.

How does The Pennant Group compare to Sotera Health?

The Pennant Group (NASDAQ:PNTG) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations and risk.

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 6.9% of The Pennant Group shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

The Pennant Group has a beta of 1.25, suggesting that its share price is 25% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.76, suggesting that its share price is 76% more volatile than the broader market.

In the previous week, The Pennant Group had 7 more articles in the media than Sotera Health. MarketBeat recorded 9 mentions for The Pennant Group and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.52 beat The Pennant Group's score of 0.70 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

The Pennant Group currently has a consensus target price of $41.00, indicating a potential downside of 2.26%. Sotera Health has a consensus target price of $20.25, indicating a potential upside of 14.08%. Given Sotera Health's higher probable upside, analysts clearly believe Sotera Health is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Sotera Health has a net margin of 9.91% compared to The Pennant Group's net margin of 2.96%. Sotera Health's return on equity of 39.73% beat The Pennant Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
Sotera Health	9.91%	39.73%	7.05%

Sotera Health has higher revenue and earnings than The Pennant Group. Sotera Health is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.54	$29.58M	$0.85	49.35
Sotera Health	$1.16B	4.35	$77.94M	$0.41	43.29

Summary

Sotera Health beats The Pennant Group on 12 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to Caris Life Sciences?

The Pennant Group (NASDAQ:PNTG) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

In the previous week, The Pennant Group and The Pennant Group both had 9 articles in the media. Caris Life Sciences' average media sentiment score of 0.77 beat The Pennant Group's score of 0.70 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Caris Life Sciences	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

The Pennant Group has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.54	$29.58M	$0.85	49.35
Caris Life Sciences	$812.03M	5.74	-$68.09M	-$7.61	N/A

The Pennant Group presently has a consensus price target of $41.00, indicating a potential downside of 2.26%. Caris Life Sciences has a consensus price target of $26.11, indicating a potential upside of 58.35%. Given Caris Life Sciences' higher probable upside, analysts clearly believe Caris Life Sciences is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Caris Life Sciences has a net margin of 3.75% compared to The Pennant Group's net margin of 2.96%. Caris Life Sciences' return on equity of 98.28% beat The Pennant Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
Caris Life Sciences	3.75%	98.28%	48.87%

85.9% of The Pennant Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 50.0% of Caris Life Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

The Pennant Group and Caris Life Sciences tied by winning 7 of the 14 factors compared between the two stocks.

How does The Pennant Group compare to Veracyte?

Veracyte (NASDAQ:VCYT) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Veracyte has a beta of 1.93, suggesting that its share price is 93% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.25, suggesting that its share price is 25% more volatile than the broader market.

85.9% of The Pennant Group shares are held by institutional investors. 1.6% of Veracyte shares are held by insiders. Comparatively, 6.9% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Veracyte has a net margin of 16.25% compared to The Pennant Group's net margin of 2.96%. The Pennant Group's return on equity of 10.07% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
The Pennant Group	2.96%	10.07%	4.23%

Veracyte has higher earnings, but lower revenue than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	9.12	$66.35M	$1.09	54.25
The Pennant Group	$947.71M	1.54	$29.58M	$0.85	49.35

Veracyte currently has a consensus price target of $55.88, suggesting a potential downside of 5.50%. The Pennant Group has a consensus price target of $41.00, suggesting a potential downside of 2.26%. Given The Pennant Group's stronger consensus rating and higher probable upside, analysts plainly believe The Pennant Group is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.60
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

In the previous week, Veracyte had 1 more articles in the media than The Pennant Group. MarketBeat recorded 10 mentions for Veracyte and 9 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.70 beat Veracyte's score of 0.69 indicating that The Pennant Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	3 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
The Pennant Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Veracyte beats The Pennant Group on 9 of the 17 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PNTG vs. The Competition

Export

Metric	The Pennant Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.46B	$6.38B	$6.84B	$12.25B
Dividend Yield	N/A	1.43%	2.68%	8.86%
P/E Ratio	49.35	42.21	27.24	23.92
Price / Sales	1.54	39.84	582.84	112.91
Price / Cash	31.27	19.21	49.25	59.89
Price / Book	3.88	3.96	10.69	6.18
Net Income	$29.58M	$218.81M	$3.59B	$331.73M
7 Day Performance	3.58%	3.73%	-2.17%	-2.30%
1 Month Performance	21.31%	17.49%	2.08%	-1.62%
1 Year Performance	75.45%	42.29%	24.68%	16.80%

The Pennant Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PNTG The Pennant Group	2.5397 of 5 stars	$41.95 +0.6%	$41.00 -2.3%	+75.5%	$1.46B	$947.71M	49.35	9,700	Analyst Forecast
BLLN Billiontoone	1.8555 of 5 stars	$120.60 +2.2%	$126.00 +4.5%	N/A	$5.43B	$305.11M	219.27	620	Gap Down
RDNT RadNet	3.5997 of 5 stars	$65.59 -3.3%	$87.43 +33.3%	+10.0%	$5.33B	$2.04B	N/A	11,264
SHC Sotera Health	3.2647 of 5 stars	$17.47 -3.1%	$20.25 +15.9%	+62.7%	$5.14B	$1.16B	42.61	3,000	News Coverage
CAI Caris Life Sciences	4.3207 of 5 stars	$17.32 -0.9%	$26.11 +50.8%	N/A	$4.94B	$812.03M	N/A	1,846	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PNTG) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Pennant Group (PNTG) Competitors

PNTG vs. BLLN, RDNT, SHC, CAI, and VCYT

How does The Pennant Group compare to Billiontoone?

Summary

How does The Pennant Group compare to RadNet?

Summary

How does The Pennant Group compare to Sotera Health?

Summary

How does The Pennant Group compare to Caris Life Sciences?

Summary

How does The Pennant Group compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PNTG vs. The Competition

The Pennant Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

The Pennant Group (PNTG) Competitors

PNTG vs. BLLN, RDNT, SHC, CAI, and VCYT

How does The Pennant Group compare to Billiontoone?

Do insiders & institutionals hold more shares of PNTG or BLLN?

Does the media prefer PNTG or BLLN?

Do analysts rate PNTG or BLLN?

Is PNTG or BLLN more profitable?

Which has preferable valuation & earnings, PNTG or BLLN?

Summary

How does The Pennant Group compare to RadNet?

Do analysts rate RDNT or PNTG?

Is RDNT or PNTG more profitable?

Which has higher earnings and valuation, RDNT or PNTG?

Which has more volatility and risk, RDNT or PNTG?

Do insiders and institutionals have more ownership in RDNT or PNTG?

Does the media refer more to RDNT or PNTG?

Summary

How does The Pennant Group compare to Sotera Health?

Do institutionals and insiders believe in PNTG or SHC?

Which has more volatility & risk, PNTG or SHC?

Does the media refer more to PNTG or SHC?

Do analysts rate PNTG or SHC?

Is PNTG or SHC more profitable?

Which has stronger valuation & earnings, PNTG or SHC?

Summary

How does The Pennant Group compare to Caris Life Sciences?

Does the media favor PNTG or CAI?

Which has preferable valuation & earnings, PNTG or CAI?

Do analysts prefer PNTG or CAI?

Is PNTG or CAI more profitable?

Do insiders & institutionals have more ownership in PNTG or CAI?

Summary

How does The Pennant Group compare to Veracyte?

Which has more volatility & risk, VCYT or PNTG?

Do institutionals & insiders have more ownership in VCYT or PNTG?

Is VCYT or PNTG more profitable?

Which has preferable earnings & valuation, VCYT or PNTG?

Do analysts prefer VCYT or PNTG?

Does the media favor VCYT or PNTG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PNTG vs. The Competition

The Pennant Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools